The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Incara Pharmaceuticals Corporation

Incara Pharmaceuticals Corporation
Nasdaq: INCR
Change
symbol:
     
 PROFILE
Development-stage Incara Pharmaceuticals is in search of the right drug for the right disease. The company is developing a treatment for inflammatory bowel disease; the drug, which is being developed in collaboration with Elan, is in clinical trials. Subsidiary Aeolus Pharmaceuticals is developing treatments for heart attack and stroke using catalytic antioxidant drugs; such drugs may also be used to treat respiratory ailments and arthritis. Incara's Renaissance Cell Technologies conducts research on liver progenitor cell therapy for treatment of liver failure. The company has research agreements with such institutions as Duke University, the University of North Carolina, and the Albert Einstein College of Medicine.

 COMPETITION
Centocor, Inc. (dossier)
Rigel Pharmaceuticals, Inc. (RIGL)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: September
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (95.2)%
Employees: 21
Revenue per employee: $4,761.90

 KEY PEOPLE
• Clayton I. Duncan
    CEO
• Richard W. Reichow
    CFO

 CONTACT INFO
3200 E. Hwy. 54, Cape Fear Bldg., Ste. 300
Research Triangle Park, NC 27709
US
Phone: 919-558-8688
Fax: 919-558-8686
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001